{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:32:08Z","timestamp":1761975128864},"reference-count":556,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":3788,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1097\/wox.0b013e3181c6c379","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T10:27:03Z","timestamp":1258540023000},"page":"233-281","source":"Crossref","is-referenced-by-count":60,"title":["Sub-Lingual Immunotherapy"],"prefix":"10.1016","volume":"2","author":[{"given":"G. Walter","family":"Canonica","sequence":"first","affiliation":[]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Casale","sequence":"additional","affiliation":[]},{"given":"Richard F.","family":"Lockey","sequence":"additional","affiliation":[]},{"given":"Carlos E.","family":"Baena-Cagnani","sequence":"additional","affiliation":[]},{"given":"Ruby","family":"Pawankar","sequence":"additional","affiliation":[]},{"given":"Paul C.","family":"Potter","sequence":"additional","affiliation":[]},{"given":"Philippe J.","family":"Bousquet","sequence":"additional","affiliation":[]},{"given":"Linda S.","family":"Cox","sequence":"additional","affiliation":[]},{"given":"Stephen R.","family":"Durham","sequence":"additional","affiliation":[]},{"given":"Harold S.","family":"Nelson","sequence":"additional","affiliation":[]},{"given":"Giovanni","family":"Passalacqua","sequence":"additional","affiliation":[]},{"given":"Dermot P.","family":"Ryan","sequence":"additional","affiliation":[]},{"given":"Jan L.","family":"Brozek","sequence":"additional","affiliation":[]},{"given":"Enrico","family":"Compalati","sequence":"additional","affiliation":[]},{"given":"Ronald","family":"Dahl","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Delgado","sequence":"additional","affiliation":[]},{"given":"Roy Gerth","family":"van Wijk","sequence":"additional","affiliation":[]},{"given":"Richard G.","family":"Gower","sequence":"additional","affiliation":[]},{"given":"Dennis K.","family":"Ledford","sequence":"additional","affiliation":[]},{"given":"Nelson Rosario","family":"Filho","sequence":"additional","affiliation":[]},{"given":"Erkka J.","family":"Valovirta","sequence":"additional","affiliation":[]},{"given":"Osman M.","family":"Yusuf","sequence":"additional","affiliation":[]},{"given":"Torsten","family":"Zuberbier","sequence":"additional","affiliation":[]},{"given":"Wahiduzzaman","family":"Akhanda","sequence":"additional","affiliation":[]},{"given":"Raul Castro","family":"Almarales","sequence":"additional","affiliation":[]},{"given":"Ignacio","family":"Ansotegui","sequence":"additional","affiliation":[]},{"given":"Floriano","family":"Bonifazi","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Ceuppens","sequence":"additional","affiliation":[]},{"given":"Tom\u00e1s","family":"Chivato","sequence":"additional","affiliation":[]},{"given":"Darina","family":"Dimova","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Dumitrascu","sequence":"additional","affiliation":[]},{"given":"Luigi","family":"Fontana","sequence":"additional","affiliation":[]},{"given":"Constance H.","family":"Katelaris","sequence":"additional","affiliation":[]},{"given":"Ranbir","family":"Kaulsay","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Kuna","sequence":"additional","affiliation":[]},{"given":"D\u00e9sir\u00e9e","family":"Larenas-Linnemann","sequence":"additional","affiliation":[]},{"given":"Manolis","family":"Manoussakis","sequence":"additional","affiliation":[]},{"given":"Kristof","family":"Nekam","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Robyn","family":"O'Hehir","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Olaguibel","sequence":"additional","affiliation":[]},{"given":"Nerin Bahceciler","family":"Onder","sequence":"additional","affiliation":[]},{"given":"Jung Won","family":"Park","sequence":"additional","affiliation":[]},{"given":"Alfred","family":"Priftanji","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Puy","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Sarmiento","sequence":"additional","affiliation":[]},{"given":"Glenis","family":"Scadding","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Schmid-Grendelmeier","sequence":"additional","affiliation":[]},{"given":"Ester","family":"Seberova","sequence":"additional","affiliation":[]},{"given":"Revaz","family":"Sepiashvili","sequence":"additional","affiliation":[]},{"given":"D\u00edrceu","family":"Sol\u00e9","sequence":"additional","affiliation":[]},{"given":"Alkis","family":"Togias","sequence":"additional","affiliation":[]},{"given":"Carlo","family":"Tomino","sequence":"additional","affiliation":[]},{"given":"Elina","family":"Toskala","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Van Beever","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Vieths","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1097\/WOX.0b013e3181c6c379_bib0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000146074","article-title":"The regulatory system in Europe with special emphasis on allergen products","volume":"147","author":"Lorenz","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0010","unstructured":"Guideline on Allergen Products. Production and quality issues. EMEA, CHMP\/BWP\/304831\/2007 adopted by CHMP November 20, 2008."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0015","unstructured":"European Pharmacopoeia 6.6. Allergen products, 01\/2010\/1063."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0025","unstructured":"Guideline on the Clinical Development of Products for Specific Immunotherapy for the Treatment of Allergic Diseases. EMEA, CHMP\/EWP\/ 18504\/2006, adopted by CHMP November 20, 2008."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0030-1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"i","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0035-1","first-page":"16","article-title":"The immunizing cure of hayfever","volume":"77","author":"Curtis","year":"1900","journal-title":"Med News (NY)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0040-1","first-page":"1156","article-title":"The oral administration ofpollen","volume":"12","author":"Black","year":"1927","journal-title":"J Lab Clin Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0045-1","first-page":"709","article-title":"The oral administration of pollen: clinical report","volume":"13","author":"Black","year":"1928","journal-title":"J Lab Clin Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0050-1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000227899","article-title":"Bronchial hypersensitization and hyposensitization in man","volume":"40","author":"Herxeimer","year":"1951","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0055-1","first-page":"159","article-title":"Further observations in induced asthma and bronchial hyposensitization","volume":"3","author":"Herxeimer","year":"1952","journal-title":"IntArch AllergyApplImmunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0060-1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2222.1975.tb01863.x","article-title":"Nasal hyposensitization and hayfever","volume":"5","author":"Metha","year":"1975","journal-title":"Clin Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0065-1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2222.1972.tb01277.x","article-title":"Local nasal desensitization in allergic rhinitis","volume":"2","author":"Taylor","year":"1972","journal-title":"Clin Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0070-1","first-page":"101","article-title":"Comparative study of immunological and clinical efficacy of oral and subcutaneous hyposensitization","volume":"3","author":"Rebien","year":"1980","journal-title":"Allergologie"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0075-1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1398-9995.1983.tb04140.x","article-title":"Orally administered grass pollen","volume":"38","author":"Taudorf","year":"1983","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0080-1","first-page":"150","article-title":"Wirksaimkeit oral hiposensibilisierung bei hausstabmilbenallergie","volume":"130","author":"Urbanek","year":"1982","journal-title":"Monatssch Kinderheilkd"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0085-1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0091-6749(89)90070-5","article-title":"Specific IgG IgE and IgA antibody response to oral immunotherapy in birch pollenosis","volume":"83","author":"Taudorf","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0090-1","doi-asserted-by":"crossref","unstructured":"Committee on the safety of medicines. CSM update. Desensitizing vaccines. BMJ. 1986;293:948.","DOI":"10.1136\/bmj.293.6552.948"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0095-1","doi-asserted-by":"crossref","unstructured":"Malling H, Weeke B, eds. Immunotherapy. Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy. 1993;48(Suppl 14):9-35.","DOI":"10.1111\/j.1398-9995.1993.tb04754.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0100-1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1986.tb01983.x","article-title":"Low dose sublingual therapy in patients with allergic rhinitis due to dust mite","volume":"16","author":"Scadding","year":"1986","journal-title":"Clin Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0105-1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0091-6749(97)70203-3","article-title":"Absorption and distribution kinetics of the mayor Parietaria allergen administered by noninjectable routes to healthy human beings","volume":"100","author":"Bagnasco","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0110-1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2222.2001.00999.x","article-title":"Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers","volume":"31","author":"Bagnasco","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0115-1","first-page":"277","article-title":"Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A doubleblind study","volume":"18","author":"Tari","year":"1990","journal-title":"Allergol Immunopathol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0120-1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.1994.tb02273.x","article-title":"A double-blind placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract","volume":"49","author":"Sabbah","year":"1994","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0125-1","doi-asserted-by":"crossref","unstructured":"Bousquet J, Lockey R, Malling HJ, eds. World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;53:1-42.","DOI":"10.1111\/j.1398-9995.1998.tb04930.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0130-1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1398-9995.1998.tb03793.x","article-title":"EAACI Position Paper on local immunotherapy","volume":"53","author":"Malling","year":"1998","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0135-1","doi-asserted-by":"crossref","unstructured":"Bousquet J, Van Cauwenberge P, eds. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl):S147-S334.","DOI":"10.1067\/mai.2001.118891"},{"issue":"Suppl 86","key":"10.1097\/WOX.0b013e3181c6c379_bib0140-1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0145-1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0091-6749(93)90166-D","article-title":"A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract","volume":"92","author":"Nelson","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0150-1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaci.2007.01.045","article-title":"Allergic rhinitis and its impact on asthma update: allergen immunotherapy","volume":"119","author":"Passalacqua","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0155-1","doi-asserted-by":"crossref","unstructured":"Wilson DR, Torres L, Durham SR. Sublingual immunotherapy for allergic rhinitis Allergy 2005;60:3-8.","DOI":"10.1111\/j.1398-9995.2005.00699.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0160-1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in children. Meta analysis of randomized controlled trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0165-1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0170-1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0175-1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1081-1206(10)60451-6","article-title":"Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial","volume":"100","author":"Pfaar","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0180-1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0185-1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0190-1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0195-1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00151829-200605040-00001","article-title":"Safety profile of sublingual immunotherapy","volume":"5","author":"Passalacqua","year":"2006","journal-title":"Treat Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0200-1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2222.2006.02429.x","article-title":"Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production","volume":"36","author":"Cosmi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0205-1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0210-1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","article-title":"Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis","volume":"114","author":"Novembre","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0215-1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1081-1206(10)60211-6","article-title":"Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study","volume":"101","author":"Marogna","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0220-1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/ACI.0b013e32831411e9","article-title":"Economic studies of immunotherapy: a review","volume":"8","author":"Berto","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0225-1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1398-9995.2008.01742.x","article-title":"The safety of sublingual immunotherapy with one or multiple pollen allergens in children","volume":"63","author":"Agostinis","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0230-1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2222.2005.02219.x","article-title":"Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years","volume":"35","author":"Di Rienzo","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0235-1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0240-1","doi-asserted-by":"crossref","unstructured":"Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol. 2007;120(Suppl):S25-S85.","DOI":"10.1016\/j.jaci.2007.06.019"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0245-1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-3038.2007.00648.x","article-title":"Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review","volume":"19","author":"Roder","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0250-1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0255-1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0260-1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaci.2005.08.027","article-title":"Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract","volume":"116","author":"Enrique","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0265-1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaci.2008.03.031","article-title":"Sublingual immunotherapy for large local reactions (LLRs) caused by honeybee sting: a double-blind, placebo-controlled trial","volume":"122","author":"Severino","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0270-2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"i","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0275-2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(01)40417-X","article-title":"Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine","volume":"ii","author":"Freeman","year":"1911","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0280-2","unstructured":"Cohen SG, Evans R III. Allergen Immunotherapy in Historical Perspective. In: Lockey RF, Ledford DK, eds. Allergens and Allergen Immunotherapy. 4th ed. New York: Informa Healthcare, 2008;1-29."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0285-2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM196509232731302","article-title":"A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever","volume":"273","author":"Lowell","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0290-2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0021-8707(68)90139-1","article-title":"Immunotherapy of hay fever with antigen E: comparisons with whole pollen extract and placebo","volume":"42","author":"Norman","year":"1968","journal-title":"J Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0295-2","first-page":"CD001936","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis","volume":"1","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0300-2","first-page":"CD001186","article-title":"Allergen immunotherapy for asthma","volume":"4","author":"Abramson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0305-2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1398-9995.1986.tb00336.x","article-title":"Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum","volume":"41","author":"Malling","year":"1986","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0310-2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0091-6749(90)90156-X","article-title":"Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract","volume":"85","author":"Horst","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0315-2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0091-6749(93)90164-B","article-title":"Emerging concepts in mold allergy: what is the role of immunotherapy","volume":"92","author":"Salvaggio","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0320-2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.27.1.39","article-title":"Value of hyposensitization therapy for perennial bronchial asthma in children","volume":"27","author":"Johnstone","year":"1961","journal-title":"Pediatrics"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0325-2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0091-6749(88)90017-6","article-title":"Doubleblind, placebo-controlled immunotherapy with mixed grass pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy","volume":"82","author":"Bousquet","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0330-2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0091-6749(91)90417-M","article-title":"Immunotherapy with cat and dog dander extracts: V. Effects of three years of treatment","volume":"87","author":"Hedlin","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0335-2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0021-8707(40)90568-8","article-title":"Serologic changes in hay fever cases treated over a period of years","volume":"11","author":"Sherman","year":"1940","journal-title":"J Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0340-2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1084\/jem.62.6.733","article-title":"Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever)","volume":"62","author":"Cooke","year":"1935","journal-title":"J Exp Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0345-2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-8707(48)90071-9","article-title":"Studies on correlation between symptoms of ragweed hay fever and titer of thermostable antibody","volume":"19","author":"Alexander","year":"1948","journal-title":"J Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0350-2","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1084\/jem.20080193","article-title":"In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure","volume":"205","author":"Meiler","year":"2008","journal-title":"J Exp Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0355-2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaci.2008.01.072","article-title":"Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity","volume":"121","author":"Francis","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0360-2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-\u03b2 cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0365-2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0091-6749(97)70106-4","article-title":"Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy","volume":"99","author":"Hamid","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0370-2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0091-6749(97)70069-1","article-title":"Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children","volume":"99","author":"Des Roches","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0375-2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1046\/j.1365-2222.2001.01161.x","article-title":"Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A Six-year follow-up study","volume":"31","author":"Pajno","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0380-2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1365-2222.2001.01027.x","article-title":"Prevention of new sensitizations in mono-sensitized subjects submitted to specific immunotherapy or not. A retrospective study","volume":"31","author":"Purello-D\u2019Ambrosio","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0385-2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect on seasonal and perennial asthma:10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0390-2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"109","author":"Moller","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0395-2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0400-2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2004.08.049","article-title":"Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract","volume":"114","author":"Nanda","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0405-2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2005.05.005","article-title":"Double-blind comparative study of cluster and conventional immunotherapy schedules and","volume":"116","author":"Tabar","year":"2005","journal-title":"Dermatophagoides pteronyssinus. J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0410-2","first-page":"409","article-title":"Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts","volume":"73","author":"Portnoy","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0415-2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1398-9995.2005.00790.x","article-title":"Efficacy and safety of preseasonally-specific immunotherapy with an aluminum-adsorbed six-grass pollen allergoid","volume":"60","author":"Corrigan","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0420-2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0091-6749(81)90200-1","article-title":"Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever","volume":"68","author":"Norman","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0425-2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2222.2007.02667.x","article-title":"Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts","volume":"37","author":"Casanovas","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0430-2","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1073\/pnas.0404735101","article-title":"Vaccination with genetically engineered allergens prevents progression of allergic disease","volume":"101","author":"Niederberger","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0435-2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1164\/ajrccm.154.6.8970345","article-title":"Treatment of cat allergy with T-cell reactive peptides","volume":"154","author":"Norman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0440-2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1371\/journal.pmed.0020078","article-title":"T cell epitope immunotherapy induces a CD 4+ T cell population with regulatory activity","volume":"2","author":"Verhoef","year":"2005","journal-title":"PLoS Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0445-2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1034\/j.1398-9995.2001.056006498.x","article-title":"A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections","volume":"56","author":"Drachenberg","year":"2001","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0450-2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa052916","article-title":"Immunotherapy with a ragweed-Toll-like receptor 9 agonist vaccine for allergic rhinitis","volume":"355","author":"Creticos","year":"2006","journal-title":"NEngl J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0455-2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0091-6749(87)90124-2","article-title":"Oral immunotherapy in birch pollen hay fever","volume":"80","author":"Taudorf","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0460-2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2005.00699.x","article-title":"Sublingual immunotherapy for allergic rhinitis","volume":"60","author":"Wilson","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0465-2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1164\/ajrccm.152.2.7633693","article-title":"Nasal Immunotherapy to Parietaria: evidence of reduction of local allergic inflammation","volume":"152","author":"Passalacqua","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0470-2","first-page":"59","article-title":"Immunotherapy by inhalation of allergen in powder in house dust allergic asthma. A double-blind study","volume":"2","author":"Tari","year":"1992","journal-title":"JInvest Allergo Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0475-2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000234127","article-title":"Local intranasal immunotherapy with high-dose polymerized ragweed extract","volume":"81","author":"Georgitis","year":"1986","journal-title":"Int Archs Allergy Appl Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0480-2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0091-6749(93)90211-W","article-title":"Local nasal Immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder inhaler","volume":"91","author":"Andri","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0485-3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1398-9995.2006.01002.x","article-title":"Immune mechanisms of allergen-specific sublingual immunotherapy","volume":"61","author":"Moingeon","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0490-3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molmed.2008.03.001","article-title":"The immune privilege of the oral mucosa","volume":"14","author":"Novak","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0495-3","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.4049\/jimmunol.172.5.3252","article-title":"Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity","volume":"172","author":"Nouri-Aria","year":"2004","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"10.1097\/WOX.0b013e3181c6c379_bib0500-3","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1073\/pnas.0404735101","article-title":"Vaccination with genetically engineered allergens prevents progression of allergic disease","volume":"101","author":"Niederberger","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0505-3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-\/3 cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0510-3","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.4049\/jimmunol.178.7.4658","article-title":"Grass pollen immunotherapy induces an allergen-specific IgA2 response associated with mucosal TGF-\u03b2 expression","volume":"178","author":"Pilette","year":"2007","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0515-3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2222.2003.01765.x","article-title":"Induction of \u2018blocking\u2019 IgG antibodies during immunotherapy","volume":"33","author":"Wachholz","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0520-3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2006.09.004","article-title":"The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses","volume":"317","author":"Shamji","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0525-3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1365-2222.2003.01699.x","article-title":"Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies","volume":"33","author":"Mothes","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0530-3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI117701","article-title":"Regulation of high-affinity IgE receptor-mediated mast cell activation by low-affinity IgG receptors","volume":"95","author":"Da\u00ebron","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0535-3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1365-2222.2001.01231.x","article-title":"Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium","volume":"31","author":"Wilson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0540-3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0091-6749(91)90297-2","article-title":"Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity","volume":"88","author":"Furin","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0545-3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(04)15592-X","article-title":"Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease","volume":"363","author":"Ling","year":"2004","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0550-3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI200423595","article-title":"Tregs and allergic disease","volume":"114","author":"Robinson","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0555-3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1067\/mai.2003.1570","article-title":"Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy","volume":"111","author":"Francis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0560-3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1365-2222.1997.tb01252.x","article-title":"Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen","volume":"27","author":"Ebner","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0565-3","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.154.8.4187","article-title":"Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures","volume":"154","author":"Jutel","year":"1995","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0570-3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2249.1997.494-ce1392.x","article-title":"IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis","volume":"110","author":"Till","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0575-3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2567.2002.01338.x","article-title":"Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios","volume":"105","author":"Wachholz","year":"2002","journal-title":"Immunology"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0580-3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0091-6749(96)70205-1","article-title":"Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma","volume":"97","author":"Durham","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0585-3","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1365-2222.1999.00651.x","article-title":"Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis","volume":"29","author":"Klimek","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0590-3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jaci.2008.03.013","article-title":"Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa","volume":"121","author":"Radulovic","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0595-3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1067\/mai.2003.1411","article-title":"Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-beta expression and prevents allergy in adult life","volume":"111","author":"Zemann","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0600-3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/90667","article-title":"Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen","volume":"2","author":"Akbari","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0605-3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1074-7613(03)00113-4","article-title":"Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo","volume":"18","author":"Wakkach","year":"2003","journal-title":"Immunity"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0610-3","first-page":"128","article-title":"Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair","volume":"83","author":"Van Wilsem","year":"1994","journal-title":"Immunology"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0615-3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1067\/mai.2003.1607","article-title":"Characterization of dendritic cells from human oral mucosa: a new Langerhans\u2019 cell type with high constitutive Fc-epsilon RI expression","volume":"112","author":"Allam","year":"2003","journal-title":"J AllergyClin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0620-3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.167.2.797","article-title":"Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells","volume":"167","author":"Novak","year":"2001","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0625-3","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.4049\/jimmunol.169.4.1810","article-title":"FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses","volume":"169","author":"von Bubnoff","year":"2002","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0630-3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2007.09.045","article-title":"Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells","volume":"121","author":"Allam","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0635-3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2222.2001.00999.x","article-title":"Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers","volume":"31","author":"Bagnasco","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0640-3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0091-6749(97)70203-3","article-title":"Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings","volume":"100","author":"Bagnasco","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0645-3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0650-3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaci.2007.10.039","article-title":"Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years","volume":"121","author":"Dahl","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0655-3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaci.2005.11.014","article-title":"Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis","volume":"117","author":"Frew","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0660-3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3038.2006.00443.x","article-title":"Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study","volume":"17","author":"Lue","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0665-3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000083320","article-title":"Lack of detectable alterations in immune responses during sublingual immunotherapy in children seasonal allergic rhinoconjunctivitis to grass pollen","volume":"136","author":"Rolinck-Werninghaus","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0670-3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1034\/j.1398-9995.2000.00495.x","article-title":"Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study","volume":"55","author":"Pajno","year":"2000","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0675-3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1398-9995.2004.00456.x","article-title":"Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy","volume":"59","author":"Tonnel","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0680-3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000083956","article-title":"Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites","volume":"136","author":"Bahceciler","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0685-3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2222.2006.02400.x","article-title":"Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children","volume":"36","author":"Dehlink","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0690-3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(97)07055-4","article-title":"Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis","volume":"351","author":"Passalacqua","year":"1998","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0695-3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0091-6749(99)70076-X","article-title":"Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: a double-blind, placebo-controlled trial","volume":"104","author":"Passalacqua","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0700-3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2003.00025.x","article-title":"Immunomodulation during sublingual therapy in allergic children","volume":"14","author":"Ippoliti","year":"2003","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0705-3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.0954-7894.2002.01327.x","article-title":"Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial","volume":"32","author":"Lima","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0710-3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1398-9995.2007.01611.x","article-title":"Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy","volume":"63","author":"Allam","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0715-3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1398-9995.2007.01519.x","article-title":"Oral reactions to sublingual immunotherapy: a bioptic study","volume":"62","author":"Marcucci","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0720-3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1034\/j.1398-9995.2001.00226.x","article-title":"Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications","volume":"56","author":"Marcucci","year":"2001","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0725-3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0730-3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000024270","article-title":"Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy","volume":"120","author":"Fanta","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0735-3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2222.2006.02429.x","article-title":"Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production","volume":"36","author":"Cosmi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0740-3","first-page":"147","article-title":"Sublingual specific immunotherapy reduces PBMC proliferations","volume":"37","author":"Fenoglio","year":"2005","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0745-3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1398-9995.2006.01206.x","article-title":"Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC","volume":"61","author":"Savolainen","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0750-3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1398-9995.2007.01426.x","article-title":"Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy","volume":"62","author":"Savolainen","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0755-3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2003.00025.x","article-title":"Immunomodulation during sublingual therapy in allergic children","volume":"14","author":"Ippoliti","year":"2003","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0760-3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.intimp.2006.03.007","article-title":"Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports","volume":"6","author":"Ciprandi","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0765-3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1081-1206(10)61186-6","article-title":"Induction of interleukin 10 by sublingual immunotherapy for HDMs: a preliminary report","volume":"95","author":"Ciprandi","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0770-3","doi-asserted-by":"crossref","unstructured":"O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, et al. House dust mite sublingual immunotherapy: the role for TGF-beta and functional regulatory T cells. Am JRespir Crit Care Med. 2009 (Aug 20) [Epub ahead of print].","DOI":"10.1164\/rccm.200905-0686OC"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0775-4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0780-4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1986.tb01983.x","article-title":"Low dose sublingual therapy in patients with allergic rhinitis due to dust mite","volume":"16","author":"Scadding","year":"1986","journal-title":"Clin Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0785-4","first-page":"277","article-title":"Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A doubleblind study","volume":"18","author":"Tari","year":"1990","journal-title":"Allergol Immunopathol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0790-4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0091-6749(93)90166-D","article-title":"A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract","volume":"92","author":"Nelson","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0795-4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.1994.tb02273.x","article-title":"A double-blind placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract","volume":"49","author":"Sabbah","year":"1994","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0800-4","first-page":"173","article-title":"Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study","volume":"23","author":"Feliziani","year":"1995","journal-title":"Allergol Immunopathol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0805-4","first-page":"25","article-title":"Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double-blind study","volume":"5","author":"Troise","year":"1995","journal-title":"JInvest Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0810-4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-3038.1997.tb00138.x","article-title":"Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extracts in children","volume":"8","author":"Hirsch","year":"1997","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0815-4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1398-9995.1998.tb04086.x","article-title":"Clinical efficacy of sublingual swallow immunotherapy: a double-blind placebo-controlled trial of a standardized five grass pollen extract in rhinitis","volume":"53","author":"Clavel","year":"1998","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0820-4","first-page":"165","article-title":"Immunotherapy with sublingual birch pollen extract: a short term double-blind study","volume":"8","author":"Horak","year":"1998","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0825-4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1398-9995.1998.tb03952.x","article-title":"Doubleblind placebo-controlled evaluation of sublingual immunotherapy with a standardized olive tree pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive tree pollen sensitization","volume":"53","author":"Vourdas","year":"1998","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0830-4","first-page":"234","article-title":"Sublingual immunotherapy with a standardized grass pollen extract: a double-blind placebo-controlled study","volume":"26","author":"Hordijk","year":"1998","journal-title":"Allergol Immunopathol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0835-4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(97)07055-4","article-title":"Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis","volume":"351","author":"Passalacqua","year":"1998","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0840-4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0091-6749(99)70076-X","article-title":"Clinical and immunological effects of a rush sublingual immunotherapy to Parietaria species: a double-blind placebo-controlled trial","volume":"104","author":"Passalacqua","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0845-4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1398-9995.1999.00916.x","article-title":"Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double-blind placebo-controlled study","volume":"54","author":"Bousquet","year":"1999","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0850-4","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1034\/j.1398-9995.1999.00203.x","article-title":"Sublingual immunotherapy: a double-blind placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma or both","volume":"54","author":"Purello D'Ambrosio","year":"1999","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0855-4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1034\/j.1398-9995.1999.00077.x","article-title":"Sublingual swallow immunotherapy (SLIT) with a standardized five grass pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis","volume":"54","author":"Pradalier","year":"1999","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0860-4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0091-6749(99)70388-X","article-title":"Double-blind placebo-controlled evaluation of sublingual swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis","volume":"104","author":"La Rosa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0865-4","first-page":"305","article-title":"Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy","volume":"9","author":"Yuksel","year":"1999","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0870-4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1034\/j.1398-9995.2000.00413.x","article-title":"House dust mite sublingual swallow immunotherapy in perennial rhinitis: a double-blind placebo controlled study","volume":"55","author":"Guez","year":"2000","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0875-4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1034\/j.1398-9995.2000.00495.x","article-title":"Clinical and immunological effects of long-term sublingual immunotherapy in asthmatic children sensitized to mite: a double-blind study","volume":"55","author":"Pajno","year":"2000","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0880-4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1034\/j.1398-9995.2000.00655.x","article-title":"Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial","volume":"55","author":"Caffarelli","year":"2000","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0885-4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0301-0546(01)79065-9","article-title":"Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double-blind study","volume":"29","author":"Ariano","year":"2001","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0890-4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.1088","article-title":"Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study","volume":"32","author":"Bahceciler","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0895-4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0301-0546(01)79041-6","article-title":"Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardized extract of tree pollen (alder, birch and hazel) administered by a rush schedule","volume":"29","author":"Voltolini","year":"2001","journal-title":"Allergol Immunopathol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0900-4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0301-0546(01)79019-2","article-title":"Garcia JA. Sublingual immunotherapy with cat epithelial extract. Personal experience","volume":"29","author":"Sanchez Palacios","year":"2001","journal-title":"Allergol Immuno-pathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0905-4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.0954-7894.2002.01327.x","article-title":"Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial","volume":"32","author":"Lima","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0910-4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2222.2003.01622.x","article-title":"Housedust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study","volume":"33","author":"Mortemousque","year":"2003","journal-title":"Clin ExpAllergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0915-4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000070926","article-title":"A double-blind placebo-controlled evaluation of SLIT with a standardized ragweed extract in patients with seasonal rhinitis","volume":"131","author":"Andr\u00e9","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0920-4","doi-asserted-by":"crossref","unstructured":"Ippoliti F, De Sanctis W, Volterrani A, Lenti L, Canitano N, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol. 2003;14216-221.","DOI":"10.1034\/j.1399-3038.2003.00025.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0925-4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1365-2222.2003.01809.x","article-title":"Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate","volume":"33","author":"Pajno","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0930-4","first-page":"145","article-title":"Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen","volume":"13","author":"Wuthrich","year":"2003","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0935-4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1398-9995.2004.00456.x","article-title":"Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy","volume":"59","author":"Tonnel","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0940-4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1398-9995.2004.00457.x","article-title":"Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study","volume":"59","author":"Bufe","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0945-4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2004.06.058","article-title":"Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis","volume":"114","author":"Smith","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0950-4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1398-9995.2004.00627.x","article-title":"A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen","volume":"59","author":"Rolinck-Werninghaus","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0955-4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1081-1206(10)61408-1","article-title":"Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis","volume":"93","author":"Bowen","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0960-4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.rmed.2005.11.016","article-title":"Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multicenter, double-blind, randomized, and placebo-controlled study in Taiwan","volume":"100","author":"Niu","year":"2006","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0965-4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","article-title":"Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis","volume":"61","author":"Dahl","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0970-4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1398-9995.2006.01095.x","article-title":"Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites","volume":"61","author":"Passalacqua","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0975-4","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0980-4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1398-9995.2006.01190.x","article-title":"Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children","volume":"61","author":"Valovirta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0985-4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0990-4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3038.2006.00443.x","article-title":"Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study","volume":"17","author":"Lue","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib0995-4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1157\/13094026","article-title":"Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study","volume":"34","author":"Palma-Carlos","year":"2006","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1000-4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3038.2006.00475.x","article-title":"Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures","volume":"18","author":"Pham-Thi","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1005-4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2006.12.651","article-title":"Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care","volume":"119","author":"Roder","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1010-4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000097026","article-title":"Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study","volume":"142","author":"Vervloet","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1015-4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1398-9995.2007.01365.x","article-title":"Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double-blind placebo-controlled study","volume":"62","author":"Alvarez-Cuesta","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1020-4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1025-4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000112506","article-title":"A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis","volume":"146","author":"Horiguchi","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1030-4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1081-1206(10)60571-6","article-title":"SUBLIM Group. Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study","volume":"99","author":"de Blay","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1035-4","first-page":"399","article-title":"Efficacy and quality of life with once-daily sublingual immunotherapy with grasses plus olive pollen extract without updosing","volume":"17","author":"Moreno-Ancillo","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1040-4","first-page":"143","article-title":"SLIT in pollen induced seasonal rhinitis and conjuncivitis: a randomized controlled trial","volume":"16","author":"Mosges","year":"2007","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1045-4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.rmed.2008.03.024","article-title":"Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually","volume":"102","author":"Panzner","year":"2008","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1050-4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2332\/allergolint.O-07-514","article-title":"A Randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis","volume":"57","author":"Okubo","year":"2008","journal-title":"Allergol Int"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1055-4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1081-1206(10)60451-6","article-title":"Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial","volume":"100","author":"Pfaar","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1060-4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5 grass pollen subllingualimmunotherapy in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1065-4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1398-9995.2008.01875.x","article-title":"Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study","volume":"64","author":"Ott","year":"2009","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1070-4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1075-4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2222.2008.03159.x","article-title":"Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen","volume":"39","author":"Stelmach","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1080-4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2009.04.037","article-title":"Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract","volume":"124","author":"Amar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1085-4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1398-9995.2005.00699.x","article-title":"Sublingual immunotherapy for allergic rhinitis","volume":"60","author":"Wilson","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1090-4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1095-4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in children. Meta analysis of randomized controlled trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1100-4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1105-4","doi-asserted-by":"crossref","unstructured":"Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009; in press.","DOI":"10.1111\/j.1398-9995.2009.02129.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1110-4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2009.04.015","article-title":"Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses","volume":"124","author":"Nieto","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1115-4","first-page":"146","article-title":"Rush sublingual immunotherapy in Parietaria allergic patients","volume":"24","author":"D'Ambrosio","year":"1996","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1120-4","first-page":"219","article-title":"Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy","volume":"25","author":"Gozalo","year":"1997","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1125-4","first-page":"41","article-title":"Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: effect on bronchial hyperreactivity","volume":"11","author":"Lombardi","year":"2001","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1130-4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1398-9995.2004.00508.x","article-title":"Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more","volume":"59","author":"Marogna","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1135-4","doi-asserted-by":"crossref","unstructured":"Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F. Dose dependence of immunological response to sublingual immunotherapy Allergy 2005;60:952-956.","DOI":"10.1111\/j.1398-9995.2005.00786.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1140-4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2005.02.031","article-title":"Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study","volume":"115","author":"Marogna","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1145-4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0301-0546(06)73518-2","article-title":"Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy","volume":"34","author":"Guerra","year":"2006","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1150-4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1081-1206(10)60718-1","article-title":"Efficacy of sublingual immunotherapy with singe or multiple allergens in polysensititzed patients","volume":"98","author":"Marogna","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1155-4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2222.1996.tb00522.x","article-title":"Sublingual vs injective immunotherapy in grass pollen allergic patients: a double-blind double-dummy study","volume":"26","author":"Quirino","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1160-4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1398-9995.2003.00387.x","article-title":"Clinical efficacy of sublingual swallow and subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis due to birch pollen. A double-blind doubledummy placebo-controlled study","volume":"59","author":"Khinchi","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1165-4","first-page":"55","article-title":"Injective VS sublingual immunotherapy in Alternaria tenuis allergic patients","volume":"6","author":"Bernardis","year":"1996","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1170-4","first-page":"461","article-title":"Humoral response to subcutaneous, oral and nasal immunotherapy for allergic rhinitis due to dermatophagoides pteronyssinus","volume":"71","author":"Piazza","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1175-4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62726-3","article-title":"Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite sensitive patients with rhinitis and asthma: a placebo-controlled study","volume":"82","author":"Mungan","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1180-4","first-page":"119","article-title":"Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study","volume":"39","author":"Mauro","year":"2007","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1185-4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaci.2005.08.027","article-title":"Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract","volume":"116","author":"Enrique","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1190-4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1398-9995.2008.01921.x","article-title":"Randomized double-blind, placebocontrolled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract","volume":"64","author":"Fern\u00e1ndez-Rivas","year":"2009","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1195-4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1185\/030079906X115711","article-title":"Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study","volume":"22","author":"Bernardini","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1200-4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2006.07738.x","article-title":"Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study","volume":"156","author":"Nettis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1205-4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"120","author":"Pajno","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1210-4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaci.2008.03.031","article-title":"Sublingual immunotherapy for large local reactions. due to honeybee sting. Double-blind placebo-controlled trial","volume":"122","author":"Severino","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1215-4","doi-asserted-by":"crossref","unstructured":"Sander I, Fleischer C, Meurer U, Bruning T, Raulf-Heimsoth M. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy 2009; in press.","DOI":"10.1111\/j.1398-9995.2009.02040.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1220-4","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.jaci.2007.12.505","article-title":"Parallel randomized double-blind placebo-controlled dose response phase IIB trial in adults for short ragweed sublingual oral immunotherapy [abst]","volume":"121","author":"Esch","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1225-4","doi-asserted-by":"crossref","unstructured":"Casale TB, Canonica GW, Bousquet J, Cox L, Lockey RF, et al. Recommendations for Appropriate Sublingual Immunotherapy (SLIT) Clinical Trials. J Allergy Clin Immunol. 2009; in press.","DOI":"10.1016\/j.jaci.2009.07.054"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1230-4","unstructured":"Committee for medicinal products for human use (CPMP). Guideline on allergen products: production and quality issues. EMEA\/CPMP\/BWP\/ 304831\/2007. London, November 28th."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1235-5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 82","key":"10.1097\/WOX.0b013e3181c6c379_bib1240-5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2006.01219_1.x","article-title":"Standards for practical allergen-specific immunotherapy","volume":"61","author":"Alvarez-Cuesta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1245-5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0091-6749(92)90129-P","article-title":"Systemic reactions from allergen immunotherapy","volume":"90","author":"Stewart","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1250-5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1398-9995.2006.01137.x","article-title":"Anaphylaxis to sublingual immunotherapy","volume":"61","author":"Dunsky","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1255-5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1398-9995.2006.01301.x","article-title":"Anaphylaxis to multiple pollen allergen sublingual immunotherapy","volume":"62","author":"Eifan","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1260-5","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1398-9995.2006.01155.x","article-title":"Anaphylaxis by latex sublingual immunotherapy","volume":"61","author":"Antico","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1265-5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1398-9995.2007.01563.x","article-title":"Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose","volume":"63","author":"Blazowski","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1270-5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1398-9995.2009.01998.x","article-title":"Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet","volume":"64","author":"de Groot","year":"2009","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1275-5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(93)90030-J","article-title":"Survey of fatalities from skin testing and immunotherapy 1985-1989","volume":"92","author":"Reid","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1280-5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0091-6749(87)80164-1","article-title":"Fatalities from immunotherapy (IT) and skin testing (ST)","volume":"79","author":"Lockey","year":"1987","journal-title":"J Allergy Clin Immunol.,"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1285-5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing:1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1290-5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2005.10.010","article-title":"Evaluation ofnear-fatal reactions to allergen immunotherapy injections","volume":"117","author":"Amin","year":"2006","journal-title":"J AllergyClin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1295-5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2222.2004.1819.x","article-title":"Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases","volume":"34","author":"Moreno","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1300-5","first-page":"489","article-title":"A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy","volume":"51","author":"Dolz","year":"1996","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1305-5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaci.2008.06.007","article-title":"Advantages and disadvantages of accelerated immunotherapy schedules","volume":"122","author":"Cox","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1310-5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","article-title":"Risk assessment in anaphylaxis: Current and future approaches","volume":"120","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1315-5","first-page":"277","article-title":"Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A doubleblind study","volume":"18","author":"Tari","year":"1990","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1320-5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.rmed.2005.11.016","article-title":"Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan","volume":"100","author":"Niu","year":"2006","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1325-5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1398-9995.2006.00959.x","article-title":"Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebocontrolled trial","volume":"61","author":"Kleine-Tebbe","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1330-5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1398-9995.2006.01203.x","article-title":"Safety and tolerability of grass pollen tablets in sublingual immunotherapy-a phase-1 study","volume":"61","author":"Larsen","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1335-5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/039463200501800210","article-title":"A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and\/or asthma","volume":"18","author":"Rossi","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1340-5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"10.1097\/WOX.0b013e3181c6c379_bib1345-5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1081-1206(10)63136-5","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology","volume":"81","author":"Bousquet","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1350-5","first-page":"S25","article-title":"Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology","volume":"120","year":"2007","journal-title":"Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1355-5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1398-9995.2004.00616.x","article-title":"Safety of sublingual immunotherapy with a monomeric allergoid in very young children","volume":"60","author":"Agostinis","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1360-5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1081-1206(10)61222-7","article-title":"Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years","volume":"95","author":"Fiocchi","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1365-5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2222.2005.02219.x","article-title":"Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years","volume":"35","author":"Rienzo","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1370-5","first-page":"71","article-title":"Sublingual immunotherapy for Allergic rhinitis and asthma in children from two to five years of age with mite allergy","volume":"55","author":"Rodriguez-Santos","year":"2008","journal-title":"Revista Alergia Mexico"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1375-5","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1398-9995.2008.01742.x","article-title":"The safety of sublingual immunotherapy with one or multiple pollen allergens in children","volume":"63","author":"Agostinis","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1380-5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1398-9995.2007.01608.x","article-title":"The safety of sublingual immunotherapy with one or more allergens in adults","volume":"63","author":"Lombardi","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1385-6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00130832-200502000-00005","article-title":"Atopic march: link to upper airways","volume":"5","author":"Spergel","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1390-6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1398-9995.2005.00717.x","article-title":"Rhinitis is an independent risk factor for developing cough apart from colds among adults","volume":"60","author":"Guerra","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1395-6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/rmed.2000.0945","article-title":"The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years","volume":"95","author":"Lombardi","year":"2001","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1400-6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaci.2003.10.010","article-title":"Association between asthma and rhinitis according to atopic sensitization in a population-based study","volume":"113","author":"Leynaert","year":"2004","journal-title":"J AllergyClin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1405-6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/rmed.2002.1319","article-title":"Rhinitis increases the risk for adult-onset asthma: a Swedish population-based case-control study (MAP-study)","volume":"96","author":"Toren","year":"2002","journal-title":"Respir Med"},{"issue":"Suppl 85","key":"10.1097\/WOX.0b013e3181c6c379_bib1410-6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2007.01551.x","article-title":"Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN","volume":"62","author":"Cruz","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1415-6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(08)61446-4","article-title":"Rhinitis and onset of asthma: a longitudinal population-based study","volume":"372","author":"Shaaban","year":"2008","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1420-6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0091-6749(75)90061-5","article-title":"Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects","volume":"56","author":"Townley","year":"1975","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1425-6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1398-9995.2006.01164.x","article-title":"The type of sensitizing allergen can affect the evolution of respiratory allergy","volume":"61","author":"Marogna","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1430-6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1067\/mai.2000.110098","article-title":"Development of seasonal allergic rhinitis during the first 7 years of life","volume":"106","author":"Kulig","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1435-6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2007.01440.x","article-title":"Today\u2019s allergic rhinitis patients are different: new factors that may play a role","volume":"62","author":"M\u00f6sges","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1440-6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0091-6749(05)80181-2","article-title":"Immediate skin test reactivity to Food and Drug Administration-approved standardized extracts","volume":"86","author":"Adinoff","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1445-6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-3038.1998.tb00356.x","article-title":"Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child","volume":"9","year":"1998","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1450-6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3038.2007.00558.x","article-title":"Early Prevention of Asthma in Atopic Children (EPAAC) Study Group. Safety of levocetirizine treatment in young atopic children: an 18-month study","volume":"18","author":"Simons","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1455-6","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa054692","article-title":"Intermittent inhaled corticosteroids in infants with episodic wheezing","volume":"354","author":"Bisgaard","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1460-6","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa051378","article-title":"Long-term inhaled corticosteroids in preschool children at high risk for asthma. An important study of inhaled corticosteroids in childhood asthma showing no preventive potential after cessation of treatment","volume":"354","author":"Guilbert","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1465-6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.42.5.793","article-title":"The value of hyposensitization therapy for bronchial asthma in children-a 14-year study","volume":"42","author":"Johnstone","year":"1968","journal-title":"Pediatrics"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1470-6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"109","author":"Moller","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1475-6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"(The PAT investigator group). Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma:10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1480-6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1046\/j.1365-2222.2001.01161.x","article-title":"Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study","volume":"31","author":"Pajno","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1485-6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1365-2222.2001.01027.x","article-title":"Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study","volume":"31","author":"Purello-D\u2019Ambrosio","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1490-6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000093250","article-title":"Long-term immunologic effects of broad-spectrum aeroallergen immunotherapy","volume":"140","author":"Limb","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1495-6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1500-6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1034\/j.1398-9995.2002.1o3264.x","article-title":"Long-term efficacy of preseasonal grass pollen immunotherapy in children","volume":"57","author":"Eng","year":"2002","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1505-6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1398-9995.2006.01011.x","article-title":"Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood","volume":"61","author":"Eng","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1510-6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","article-title":"Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis","volume":"114","author":"Novembre","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1515-6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1081-1206(10)60211-6","article-title":"Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study","volume":"101","author":"Marogna","year":"2008","journal-title":"Ann AllergyAsthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1520-6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1398-9995.2004.00578.x","article-title":"Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial","volume":"59","author":"Pajno","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1525-6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2005.02.031","article-title":"Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study","volume":"115","author":"Marogna","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1530-6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1398-9995.2004.00508.x","article-title":"Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more","volume":"59","author":"Marogna","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1535-6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-2222.2003.01587.x","article-title":"Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study","volume":"33","author":"Di Rienzo","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1540-6","doi-asserted-by":"crossref","unstructured":"Marogna M, Spadolini I, Massolo A, et al. Longlastingeffect according to the duration of SLIT: a 15-year prospective study [abst]. XXVI EAACI Meeting, Goteborg 2007:276.","DOI":"10.1097\/01.WOX.0000301143.20571.71"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1545-6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000096001","article-title":"Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life","volume":"142","author":"Marogna","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1550-6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/MLG.0b013e31804f8141","article-title":"Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis","volume":"117","author":"Tahamiler","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1555-6","unstructured":"Committee for medicinal products for human use. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. CHMP\/EWP\/18504\/2006. London. European Medicines Agency. Pre-authorisation evaluation ofmedicines for human use. 20 November 2008."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1560-7","first-page":"277","article-title":"Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study","volume":"18","author":"Tari","year":"1990","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1565-7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1570-7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-3038.2007.00648.x","article-title":"Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review","volume":"19","author":"Roder","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1575-7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1399-3038.2008.00809.x","article-title":"Sublingual immunotherapy in children: more optimism today","volume":"20","author":"Larenas-Linnemann","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1580-7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1398-9995.2006.01190.x","article-title":"Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children","volume":"61","author":"Valovirta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1585-7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1590-7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1595-7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2006.12.651","article-title":"Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care","volume":"119","author":"Roder","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1600-7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1398-9995.1998.tb03952.x","article-title":"Doubleblind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization","volume":"53","author":"Vourdas","year":"1998","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1605-7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1398-9995.2004.00457.x","article-title":"Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study","volume":"59","author":"Bufe","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1610-7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1034\/j.1398-9995.2000.00495.x","article-title":"Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study","volume":"55","author":"Pajno","year":"2000","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1615-7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.1088","article-title":"Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study","volume":"32","author":"Bahceciler","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1620-7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.rmed.2005.11.016","article-title":"Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multicenter, double-blind, randomized, and placebo-controlled study in Taiwan","volume":"100","author":"Niu","year":"2006","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1625-7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-3038.1997.tb00138.x","article-title":"Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children","volume":"8","author":"Hirsch","year":"1997","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1630-7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3038.2006.00475.x","article-title":"Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures","volume":"18","author":"Pham-Thi","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1635-7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1640-7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/ACI.0b013e3280895d36","article-title":"New perspectives in the treatment of allergic rhinitis and asthma in children","volume":"7","author":"Baena-Cagnani","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1645-7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11882-007-0063-6","article-title":"Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations","volume":"7","author":"Cox","year":"2007","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1650-7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1365-2222.2003.01809.x","article-title":"Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate","volume":"33","author":"Pajno","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1655-7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"120","author":"Pajno","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1660-7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1398-9995.2006.01196.x","article-title":"Sublingual immunotherapy for cow\u2019s milk protein allergy: a preliminary report","volume":"61","author":"de Boissieu","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1665-7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1185\/030079906X115711","article-title":"Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study","volume":"22","author":"Bernardini","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1670-7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157488607780598340","article-title":"The safety of allergen specific sublingual immunotherapy","volume":"2","author":"Passalacqua","year":"2007","journal-title":"Curr Drug Saf"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1675-7","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1398-9995.2008.01742.x","article-title":"The safety of sublingual immunotherapy with one or multiple pollen allergens in children","volume":"63","author":"Agostinis","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1680-8","unstructured":"Current status of allergen immunotherapy. Shortened version of a World Health Organisation\/International Union of Immunological Societies Working Group Report. Lancet. 1989;1:259-261."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1685-8","doi-asserted-by":"crossref","unstructured":"Malling H. Immunotherapy. Position Paper of the EAACI. Allergy. 1988;43(Suppl 6).","DOI":"10.1111\/j.1398-9995.1988.tb04767.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1690-8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1081-1206(10)63136-5","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology","volume":"81","author":"Bousquet","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1695-8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1398-9995.1998.tb03793.x","article-title":"Local immunotherapy","volume":"53","author":"Malling","year":"1998","journal-title":"Allergy"},{"issue":"Suppl","key":"10.1097\/WOX.0b013e3181c6c379_bib1700-8","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1705-8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1710-8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaci.2007.01.045","article-title":"Allergic rhinitis and its impact on asthma update: allergen immunotherapy","volume":"119","author":"Passalacqua","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 86","key":"10.1097\/WOX.0b013e3181c6c379_bib1715-8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1720-8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3038.2006.00475.x","article-title":"Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures","volume":"18","author":"Pham-Thi","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1725-8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"JAllergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1730-8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1081-1206(10)60451-6","article-title":"Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial","volume":"100","author":"Pfaar","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1735-8","first-page":"143","article-title":"Sublingual immunotherapy in pollen-induced seasonal rhinitis and conjunctivitis: a randomized controlled trial","volume":"16","author":"Mosges","year":"2007","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1740-8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1081-1206(10)60571-6","article-title":"Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study","volume":"99","author":"de Blay","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1745-8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1398-9995.2006.01305.x","article-title":"GINA guidelines on asthma and beyond","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1750-8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2007.01594.x","article-title":"Consensus statements, evidence-based medicine and guidelines in allergic diseases","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1755-8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/014107689508801105","article-title":"The need for evidence-based medicine","volume":"88","author":"Sackett","year":"1995","journal-title":"J R Soc Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1760-8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.324.7339.729","article-title":"Clinical problem solving and diagnostic decision making: selective review of the cognitive literature","volume":"324","author":"Elstein","year":"2002","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1765-8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bmj.321.7256.255","article-title":"Which clinical studies provide the best evidence? The best RCT still trumps the best observational study","volume":"321","author":"Barton","year":"2000","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1770-8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/bmj.324.7336.545\/a","article-title":"Quality of Cochrane reviews. Quality ofCochrane reviews is better than thatofnon-Cochrane reviews","volume":"324","author":"Petticrew","year":"2002","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1775-8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials","volume":"9","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1780-8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1785-8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-3038.2007.00648.x","article-title":"Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review","volume":"19","author":"Roder","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1790-8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1795-8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rmed.2004.03.026","article-title":"How representative are clinical study patients with asthma or COPD for a larger \u201creal life\u201d population of patients with obstructive lung disease","volume":"99","author":"Herland","year":"2005","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1800-8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-6963-5-25","article-title":"Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system","volume":"5","author":"Atkins","year":"2005","journal-title":"BMC Health Serv Res"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1805-8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Schunemann","year":"2006","journal-title":"Am JRespir Crit Care Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1810-8","unstructured":"Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations. www.evidence-basedmedicine.com; Module 37. Topic 20052011:189."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1815-8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bmj.327.7406.65","article-title":"Balancing benefits and harms in health care","volume":"327","author":"Cuervo","year":"2003","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1820-8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bmj.323.7312.546","article-title":"Assessment of therapeutic safety in systematic reviews: literature review","volume":"323","author":"Ernst","year":"2001","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1825-8","unstructured":"Global Programme on Evidence for Health Policy. Guidelines for WHO Guidelines. EIP\/GPE\/EQC\/2003.1. Geneva, World Health Organization; 2003. 2003."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1830-8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1835-8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","author":"Shekelle","year":"1999","journal-title":"BMJ"},{"issue":"Suppl 14","key":"10.1097\/WOX.0b013e3181c6c379_bib1840-8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1398-9995.1993.tb04754.x","article-title":"Immunotherapy. Position Paper of the European Academy of Allergy and Clinical Immunology","volume":"48","author":"Malling","year":"1993","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1845-8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jaci.2007.01.029","article-title":"2006 American Academy of Allergy, Asthma & Immunology member immunotherapy practice patterns and concerns","volume":"119","author":"Coifman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1850-8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaci.2005.11.014","article-title":"Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis","volume":"117","author":"Frew","year":"2006","journal-title":"JAllergyClin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1855-8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"JAllergyClin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1860-8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1398-9995.2007.01402.x","article-title":"Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage","volume":"62","author":"Durham","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1865-8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1870-8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1398-9995.2006.01190.x","article-title":"Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children","volume":"6","author":"Valovirta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1875-8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1880-8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"JAllergyClin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1885-8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","article-title":"Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis","volume":"61","author":"Dahl","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1890-8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/ACI.0b013e3282f1d6a4","article-title":"Immunotherapy: clinical trials-optimal trial and clinical outcomes","volume":"7","author":"Bousquet","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1895-8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1900-8","unstructured":"Committee for medicinal products for human use (CPMP). Guideline on allergen products: production and quality issues. EMEA\/CHMP\/BWP\/ 304831\/2007. London, 20 November 2008. 2008."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1905-8","unstructured":"Bousquet P, Delgado L. WAO Methodology of sublingual immunotherapy trials. Allergy 2009;(Suppl). In press."},{"issue":"Suppl 82","key":"10.1097\/WOX.0b013e3181c6c379_bib1910-8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2006.01219_1.x","article-title":"Standards for practical allergen-specific immunotherapy","volume":"61","author":"Alvarez-Cuesta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1915-8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1398-9995.2008.01648.x","article-title":"Reply to the letter by Dr Fleming Madsen (EAACI \u2019Standards for practical allergen-specific immunotherapy\u2019)","volume":"63","author":"Alvarez-Cuesta","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1920-8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1398-9995.2007.01563.x","article-title":"Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose","volume":"63","author":"Blazowski","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1925-8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1398-9995.2007.01608.x","article-title":"The safety of sublingual immunotherapy with one or more allergens in adults","volume":"63","author":"Lombardi","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1930-8","unstructured":"Cox L. Safety ofsublingual immunotherapy. Allergy2009;(Suppl). In press."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1935-8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1398-9995.2008.01868.x","article-title":"Late side-effects during systemic immunotherapy in children","volume":"63","author":"Caubet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1940-8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1081-1206(10)61222-7","article-title":"Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years","volume":"95","author":"Fiocchi","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1945-8","first-page":"148","article-title":"Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France","volume":"39","author":"Omnes","year":"2007","journal-title":"Allerg Immunol (Paris)"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1950-8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2222.2007.02706.x","article-title":"Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis: a Northern European perspective","volume":"37","author":"Bachert","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1955-8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.rmed.2007.05.003","article-title":"Cost-effectiveness of GRAZAX((R)) for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe","volume":"101","author":"Canonica","year":"2007","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1960-8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1398-9995.2008.01743.x","article-title":"Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis coexisting with asthma","volume":"63","author":"Nasser","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1965-8","doi-asserted-by":"crossref","unstructured":"Grazax for hay fever? Drug Ther Bull. 2008;46:9-10.","DOI":"10.1136\/dtb.2008.01.0001"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1970-8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01053.x","article-title":"The use of quality-adjusted life-years in cost-effectiveness studies","volume":"61","author":"Sculpher","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1975-8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1081-1206(10)60498-X","article-title":"Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma","volume":"101","author":"Bruggenjurgen","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1980-8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1398-9995.1998.tb04086.x","article-title":"Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis","volume":"53","author":"Clavel","year":"1998","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1985-8","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.jaci.2007.12.507","article-title":"Phase III trial with grass allergen tablet for sublingual immunotherapy in children","volume":"121","author":"Bufe","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1990-8","unstructured":"Global strategy for asthma management and prevention. GINA. Update from NHLBI\/WHO Workshop Report 1995, Revised 2006. www.ginas-thma.com 2006."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib1995-8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-9995.2007.01586.x","article-title":"Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report","volume":"63","author":"Bacharier","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2000-9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: Therapeutic vaccines for allergic diseases","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2005-9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2010-9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce the general validity of the results","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2015-9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a metanalysis of randomized, placebo-controlled, double-blind trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2020-9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/adc.2003.030411","article-title":"Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature","volume":"89","author":"Sopo","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2025-9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1398-9995.2004.00616.x","article-title":"Safety of sublingual immunotherapy with a monomeric allergoid in very young children","volume":"60","author":"Agostini","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2030-9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 Years of Age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2035-9","unstructured":"Global strategy for asthma management and prevention. WHO\/NHLBI workshop report. National Institutes ofHealth, National Heart, Lung and Blood Institute; Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2040-9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-2222.2003.01587.x","article-title":"Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study","volume":"33","author":"DiRienzo","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"Suppl 86","key":"10.1097\/WOX.0b013e3181c6c379_bib2045-9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2050-9","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2055-9","doi-asserted-by":"crossref","unstructured":"Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007: CD001936.","DOI":"10.1002\/14651858.CD001936.pub2"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2060-9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2065-9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaci.2008.03.031","article-title":"Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial","volume":"122","author":"Severino","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2070-9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized double-blind placebo-controlled study","volume":"120","author":"Pajno","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2075-9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaci.2005.08.027","article-title":"Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo controlled study with a standardized hazelnut extract","volume":"116","author":"Enrique","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2080-9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2006.07738.x","article-title":"Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study","volume":"156","author":"Nettis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2085-9","first-page":"17","article-title":"Tolerance and effects on skin reactivityto latex ofsublingual rush immunotherapy with a latex extract","volume":"14","author":"Bahima","year":"2004","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2090-9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2009.02.012","article-title":"Evaluation of serum s-IgE\/total IgE ratio in predicting clinical response to allergen-specific immunotherapy","volume":"123","author":"Di Lorenzo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2095-10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1183\/09031936.00.16580200","article-title":"Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study","volume":"16","author":"Rabe","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2100-10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pcrj.2005.03.009","article-title":"Management of allergic rhinitis in UK primary care: baseline audit","volume":"14","author":"Ryan","year":"2005","journal-title":"Prim Care Respir J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2105-10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bmj.304.6831.873","article-title":"Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years art","volume":"304","author":"Ninan","year":"1992","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2110-10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/bmj.327.7424.1142","article-title":"Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data","volume":"327","author":"Gupta","year":"2003","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2115-10","unstructured":"Haubrich WS. Medical meanings: a glossary ofword origins (Book). ACP Press, 2004. ISBN:1930513496, 9781930513495; page 10."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2120-10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1398-9995.2008.01655.x","article-title":"General practitioners\u2019 central role in management of asthma and allergic rhinitis","volume":"63","author":"van Weel","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2125-10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1398-9995.2008.01653.x","article-title":"Primary care: the cornerstone of diagnosis of allergic rhinitis","volume":"63","author":"Ryan","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2130-10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3132\/pcrj.2007.00004","article-title":"Undergraduate allergy teaching in a UK medical school: comparison of the described and delivered curriculum","volume":"16","author":"Shehata","year":"2007","journal-title":"Primary Care Resp J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2135-10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1081-1206(10)61492-5","article-title":"Physician attitudes, opinions, and referral patterns: comparisons of those who have and have not taken an allergy\/ immunology rotation","volume":"9","author":"Baptist","year":"2004","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2140-10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1939-4551-2-8-150","article-title":"Recommendations for competency in allergy training for undergraduates qualifying as medical practitioners: a Position Paper of the World Allergy Organization","volume":"2","author":"Potter","year":"2009","journal-title":"World Allergy Org J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2145-10","doi-asserted-by":"crossref","unstructured":"House dust mite control measures in the management of asthma: metaanalysis. BMJ. 1998;317(7166):1105-1110; discussion 1110.","DOI":"10.1136\/bmj.317.7166.1105"},{"issue":"Suppl 86","key":"10.1097\/WOX.0b013e3181c6c379_bib2150-10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2155-10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.00138707","article-title":"Global strategy for asthma management and prevention: GINA executive summary","volume":"31","author":"Bateman","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2160-10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcrj.2005.11.002","article-title":"International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis","volume":"15","author":"Price","year":"2006","journal-title":"Prim Care Respir J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2165-10","unstructured":"CSM update: desensitising vaccines. BMJ. (Clin Res Ed) 1986;293:948."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2170-10","unstructured":"Kramer J, Crocetti S. JHQ 132: allergy immunotherapy in the primary care setting. J Healthcare Qual. http:\/\/www.nahq.org\/journal\/ce\/arti-cle.html?articleid=162."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2175-10","unstructured":"Craig T, Sawyer AM, Fornadley JA. Use of immunotherapy in a primary care office. Am Fam Physician. http:\/\/www.aafp.org\/afp\/980415ap\/craig.html."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2180-10","first-page":"675","article-title":"The role of allergens in asthma","volume":"76","author":"Platts-Mills","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2185-10","first-page":"2","article-title":"Allergen immunotherapy: a practice parameter","volume":"90","author":"James","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2190-10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1399-3038.2007.00651.x","article-title":"Paediatric allergy diagnosis in primary care is improved by in vitro allergen-specific IgE testing","volume":"19","author":"Niggemann","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2195-10","doi-asserted-by":"crossref","unstructured":"Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001936. DOI:10.1002\/14651858.CD001936.pub2.","DOI":"10.1002\/14651858.CD001936.pub2"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2200-10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2222.2004.1819.x","article-title":"On behalf of the SEAIC Immunotherapy safety: a prospective multi-centre monitoring study of biologically standardised therapeutic vaccines for allergic disease","volume":"34","author":"Moreno","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2205-10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2004.06.058","article-title":"Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis","volume":"114","author":"Smith","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2210-10","doi-asserted-by":"crossref","unstructured":"BMJ Group. Grazax for hay fever? Drug Ther Bull. 2008;46:9-10.","DOI":"10.1136\/dtb.2008.01.0001"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2215-10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000071547","article-title":"Local immunotherapy in allergy: prospects for the future","volume":"82","author":"Markert","year":"2003","journal-title":"Chem Immunol Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2220-10","doi-asserted-by":"crossref","unstructured":"Halken S, Lau S, Valovirta E. New visions in specific immunotherapy in children: an iPAC summary and future trends. Pediatr Allergy Immunol. 2008;(Suppl 19):60-70.","DOI":"10.1111\/j.1399-3038.2008.00768.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2225-10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1081-1206(10)60451-6","article-title":"Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebocontrolled trial","volume":"100","author":"Pfaar","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2230-10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/14712598.8.3.291","article-title":"Sublingual immunotherapy in children","volume":"8","author":"van Wijk","year":"2008","journal-title":"Exp Opin Biol Ther"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2235-10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2240-10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/014556130708600816","article-title":"Efficacy comparison of multiple-antigen subcutaneous injection immunotherapy and multiple-antigen sublingual immunotherapy","volume":"86","author":"Saporta","year":"2007","journal-title":"Ear Nose Throat J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2245-10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157488607780598340","article-title":"The safety of allergen specific sublingual immunotherapy","volume":"2","author":"Passalacqua","year":"2007","journal-title":"Curr Drug Saf"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2250-10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1081-1206(10)60496-6","article-title":"Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy","volume":"101","author":"Rodr\u00edguez-P\u00e9rez","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2255-10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1081-1206(10)60474-7","article-title":"Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results","volume":"100","author":"Esch","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2260-10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MOO.0b013e3282fc706f","article-title":"Sublingual immunotherapy","volume":"16","author":"Esch","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2265-10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2296-9-59","article-title":"Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment","volume":"9","author":"de Bot","year":"2008","journal-title":"BMC Fam Pract"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2270-10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.amjmed.2006.02.019","article-title":"Allergy immunotherapy for primary care physicians","volume":"119","author":"Stokes","year":"2006","journal-title":"Am J Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2275-10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001786-200604000-00015","article-title":"Allergy immunotherapy in the primary care setting: integrating national practice standards to promote safe delivery","volume":"21","author":"Charron","year":"2006","journal-title":"J Nurs Care Qual"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2280-10","doi-asserted-by":"crossref","unstructured":"Kramer J, Crocetti S. Allergy immunotherapy in the primary care setting. J Health Qual. 2003;25:8-13 quiz 13-14.","DOI":"10.1111\/j.1945-1474.2003.tb01082.x"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2285-10","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.rmed.2007.05.003","article-title":"Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe","volume":"101","author":"Canonica","year":"2007","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2290-10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1081-1206(10)60498-X","article-title":"Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma","volume":"101","author":"Br\u00fcggenj\u00fcrgen","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2295-10","doi-asserted-by":"crossref","unstructured":"Weber RW. Allergic rhinitis. Prim Care. 2008;35:1-10, v","DOI":"10.1016\/j.pop.2007.09.001"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2300-10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1185\/030079908X253726","article-title":"Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study","volume":"24","author":"Berto","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2305-10","first-page":"143","article-title":"Sublingual immunotherapy in pollen-induced seasonal rhinitis and conjunctivitis: a randomized controlled trial","volume":"16","author":"M\u00f6sges","year":"2007","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2310-10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1399-3038.2007.00604.x","article-title":"Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration","volume":"19","author":"Ant\u00fanez","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2315-10","first-page":"375","article-title":"Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period","volume":"17","author":"Nuhoglu","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2320-10","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1185\/030079907X226096","article-title":"Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study","volume":"23","author":"Cadario","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2325-10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1399-3038.2007.00549.x","article-title":"Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma","volume":"18","author":"Ozdemir","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2330-10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"120","author":"Pajno","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2335-10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000096001","article-title":"Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life","volume":"142","author":"Marogna","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2340-10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3038.2006.00443.x","article-title":"Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study","volume":"17","author":"Lue","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2345-10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1081-1206(10)60718-1","article-title":"Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients","volume":"98","author":"Marogna","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2350-10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1067\/mai.2001.113525","article-title":"Sublingual immunotherapy","volume":"107","author":"Frew","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2355-10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pcrj.2005.01.003","article-title":"Management of allergic problems in primary care: time for a rethink","volume":"14","author":"Ryan","year":"2005","journal-title":"Prim Care Respir J"},{"issue":"Suppl 81","key":"10.1097\/WOX.0b013e3181c6c379_bib2360-11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1398-9995.2006.01158.x","article-title":"Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials","volume":"61","author":"Malling","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2365-11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1398-9995.2005.00699.x","article-title":"Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis","volume":"60","author":"Wilson","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2370-11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2375-11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2380-11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-3038.2007.00648.x","article-title":"Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review","volume":"19","author":"Roder","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2385-11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2006.12.651","article-title":"Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care","volume":"119","author":"Roder","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2390-11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2395-11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2400-11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"JAllergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2405-11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1081-1206(10)60451-6","article-title":"Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial","volume":"100","author":"Pfaar","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2410-11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1398-9995.2006.01190.x","article-title":"Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children","volume":"61","author":"Valovirta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2415-11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2420-11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2425-11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1398-9995.2007.01560.x","article-title":"Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update","volume":"63","author":"Brozek","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2430-11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2435-11","unstructured":"Committee for medicinal products for human use. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. CHMP\/EWP\/18504\/2006. London. European Medicines Agency. Pre-authorisation evaluation of medicines for human use. 20 November 2008."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2440-11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000146074","article-title":"The regulatory system in Europe with special emphasis on allergen products","volume":"147","author":"Lorenz","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2445-11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"120","author":"Pajno","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2450-11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2006.07738.x","article-title":"Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study","volume":"156","author":"Nettis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2455-11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.all.0000246618.41871.a4","article-title":"Specific immunotherapy for food allergy: basic principles and clinical aspects","volume":"6","author":"Enrique","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2460-11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1398-9995.2006.01196.x","article-title":"Sublingual immunotherapy for cow\u2019s milk protein allergy: a preliminary report","volume":"61","author":"de Boissieu","year":"2006","journal-title":"Allergy"},{"issue":"Pt 1","key":"10.1097\/WOX.0b013e3181c6c379_bib2465-11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1081-1206(10)63136-5","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology","volume":"81","author":"Bousquet","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2470-11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1398-9995.2007.01612.x","article-title":"The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification","volume":"63","author":"van Ree","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2475-11","unstructured":"Committee for medicinal products for human use (CPMP). Guideline on allergen products: production and quality issues. EMEA\/CHMP\/BWP\/ 304831\/2007. London, 20 November 2008."},{"issue":"Suppl 82","key":"10.1097\/WOX.0b013e3181c6c379_bib2480-11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2006.01219_1.x","article-title":"Standards for practical allergen-specific immunotherapy","volume":"61","author":"Alvarez-Cuesta","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2485-11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1398-9995.2008.01648.x","article-title":"Reply to the letter by Dr Fleming Madsen (EAACI \u2019Standards for practical allergen-specific immunotherapy\u2019)","volume":"63","author":"Alvarez-Cuesta","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2490-11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000151243","article-title":"The principle of homologous groups in regulatory affairs of allergen products: a proposal","volume":"148","author":"Lorenz","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2495-11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1398-9995.2007.01581.x","article-title":"Assessing skin prick tests reliability in ECRHS-I","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"Suppl 86","key":"10.1097\/WOX.0b013e3181c6c379_bib2500-11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2505-11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.00138707","article-title":"Global strategy for asthma management and prevention: GINA executive summary","volume":"31","author":"Bateman","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2510-11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1034\/j.1398-9995.2000.00413.x","article-title":"House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study","volume":"55","author":"Guez","year":"2000","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2515-11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1398-9995.2004.00456.x","article-title":"Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy","volume":"59","author":"Tonnel","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2520-11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1398-9995.2008.01807.x","article-title":"Understanding patient sensitization profiles in complex pollen areas: a molecular epidemiological study","volume":"63","author":"Barber","year":"2008","journal-title":"Allergy"},{"issue":"Pt 1","key":"10.1097\/WOX.0b013e3181c6c379_bib2525-11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0091-6749(89)90369-2","article-title":"Double-blind, placebo-controlled immunotherapy with mixed grasspollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma","volume":"84","author":"Bousquet","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2530-11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1398-9995.1998.tb04086.x","article-title":"Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis","volume":"53","author":"Clavel","year":"1998","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2535-11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1398-9995.2008.01690.x","article-title":"House dust mite control measures for asthma: systematic review","volume":"63","author":"Gotzsche","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2540-11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1398-9995.2006.00959.x","article-title":"Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial","volume":"61","author":"Kleine-Tebbe","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2545-11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1398-9995.2006.01203.x","article-title":"Safety and tolerability of grass pollen tablets in sublingual immunotherapy-a phase-1 study","volume":"61","author":"Larsen","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2550-11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1081-1206(10)60474-7","article-title":"Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results","volume":"100","author":"Esch","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2555-11","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.rmed.2007.05.003","article-title":"Cost-effectiveness of GRAZAX((R)) for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe","volume":"101","author":"Canonica","year":"2007","journal-title":"Respir Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2560-11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000088719","article-title":"Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers","volume":"138","author":"Bagnasco","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2565-11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0091-6749(97)70203-3","article-title":"Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings","volume":"100","author":"Bagnasco","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2570-11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1398-9995.2003.00387.x","article-title":"Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study","volume":"59","author":"Khinchi","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2575-11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2004.06.058","article-title":"Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis","volume":"114","author":"Smith","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2580-11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1398-9995.2006.01095.x","article-title":"Randomized double-blind controlled study with sublingual carbamy-lated allergoid immunotherapy in mild rhinitis due to mites","volume":"61","author":"Passalacqua","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2585-11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/ACI.0b013e3282f1d6a4","article-title":"Immunotherapy: clinical trials\u2014optimal trial and clinical outcomes","volume":"7","author":"Bousquet","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2590-11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1398-9995.1999.00916.x","article-title":"Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study [In Process Citation]","volume":"54","author":"Bousquet","year":"1999","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2595-11","doi-asserted-by":"crossref","unstructured":"Altman DG, Moher D, Schulz KF. Peer review of statistics in medical research. Reporting power calculations is important. BMJ. 2002;325:491; author reply.","DOI":"10.1136\/bmj.325.7362.491\/a"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2600-11","doi-asserted-by":"crossref","unstructured":"Schulz KF, Moher D, Altman DG. Interpreting the number needed to treat. JAMA. 2002;288:831; author reply-2.","DOI":"10.1001\/jama.288.19.2406-JLT1120-4-1"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2605-11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11136-006-9110-3","article-title":"Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study","volume":"16","author":"Rak","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2610-11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1398-9995.2007.01469.x","article-title":"Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials","volume":"62","author":"Clark","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2615-11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1398-9995.2007.01402.x","article-title":"Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage","volume":"62","author":"Durham","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2620-11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1398-9995.2006.01206.x","article-title":"Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC","volume":"61","author":"Savolainen","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2625-11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1398-9995.2007.01426.x","article-title":"Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy","volume":"62","author":"Savolainen","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2630-11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1398-9995.2008.01727.x","article-title":"Serum vascular endothelial growth factor and sublingual immunotherapy","volume":"63","author":"Ciprandi","year":"2008","journal-title":"Allergy,"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2635-11","unstructured":"International Conference on Harmonisation Topic E 3. Structure and Content of Clinical Study Reports: Note for guidance on structure and content of clinical study reports. CPMP\/ICH\/137\/95 (1996)."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2640-11","unstructured":"International Conference on Harmonisation. Topic E10: ICH E10 Choice of Control (roup in Clinical Trials, (2000)."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2645-11","unstructured":"Sackett D, Straus S, Richardson W, Rosenberg W, Haynes R. Evidence-based medicine: how to practice and teach ebm. (2d ed). Oxford: Churchill Livingstone; 2000."},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2650-11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2655-11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1398-9995.2007.01608.x","article-title":"The safety of sublingual immunotherapy with one or more allergens in adults","volume":"63","author":"Lombardi","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2660-11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2665-11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2670-11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1398-9995.2005.00895.x","article-title":"Standard skin prick testing and sensitization to inhalant allergens across Europe-a survey from the GALEN network","volume":"60","author":"Heinzerling","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2675-11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2005.00700.x","article-title":"Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms","volume":"60","author":"Bousquet","year":"2005","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2680-11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000097026","article-title":"Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study","volume":"142","author":"Vervloet","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2685-11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1398-9995.2007.01416.x","article-title":"Prolonged pre-seasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy","volume":"62","author":"Calderon","year":"2007","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2690-11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bmj.331.7519.750","article-title":"Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial","volume":"331","author":"Fairall","year":"2005","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2695-11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1034\/j.1398-9995.2003.00076.x","article-title":"Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial","volume":"58","author":"Bousquet","year":"2003","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2700-11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaci.2004.03.013","article-title":"Quantitative assessment of the adherence to sublingual immunotherapy","volume":"113","author":"Lombardi","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2705-11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jaci.2005.07.034","article-title":"Children\u2019s compliance with allergen immunotherapy according to administration routes","volume":"116","author":"Pajno","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2710-11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-3038.2006.00471.x","article-title":"Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year)","volume":"18","author":"Passalacqua","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2715-11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1365-2222.2008.03060.x","article-title":"Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial","volume":"38","author":"Roder","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2720-11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2007.10.026","article-title":"Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs","volume":"121","author":"Hankin","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2725-11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2730-11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","article-title":"Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration","volume":"148","author":"Boutron","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2735-11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2740-11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","article-title":"Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis","volume":"61","author":"Dahl","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2745-11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1398-9995.2006.01088.x","article-title":"Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics","volume":"61","author":"Blumberga","year":"2006","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2750-11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3038.2006.00475.x","article-title":"Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures","volume":"18","author":"Pham-Thi","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2755-11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2222.2005.02219.x","article-title":"Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years","volume":"35","author":"Rienzo","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2760-11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000096001","article-title":"Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life","volume":"142","author":"Marogna","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2765-11","doi-asserted-by":"crossref","unstructured":"BMJ Group. Grazax for hay fever? Drug Ther Bull. 2008;46:9-10.","DOI":"10.1136\/dtb.2008.01.0001"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2770-11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2222.2007.02706.x","article-title":"Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis: a Northern European perspective","volume":"37","author":"Bachert","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2775-11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1398-9995.2008.01743.x","article-title":"Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis coexisting with asthma","volume":"63","author":"Nasser","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181c6c379_bib2780-11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1081-1206(10)60475-9","article-title":"Economic evaluation of sublingual vs subcutaneous allergen immunotherapy","volume":"100","author":"Pokladnikova","year":"2008","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119305551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119305551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:57:33Z","timestamp":1685203053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119305551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":556,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1939455119305551"],"URL":"https:\/\/doi.org\/10.1097\/wox.0b013e3181c6c379","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}